Experienced in Digital Health and mHealth technologies, Electronic Medical Records data mining, and Precision Medicine assessments, Barbara provides strategic insight integrating cutting edge technology with healthcare advances.
Barbara is a new medicines development expert with a proven track record for providing Pharma management with fact-based, analyzed scientific and competitive/marketing information to facilitate successful transition of projects from early research through product launch. She works closely with scientific and business experts in Biotech and Pharmaceuticals and with Digital Health and Personalized Medicine practitioners.
Successful projects include indication prioritization and portfolio assessments, Situation Analyses, personalized healthcare initiatives, quantifying opportunities for biomarkers and companion diagnostics, and preparing population estimates for patients at risk for drug-drug-interactions.
Barbara is a graduate of Brown University, A.B. Biology, and is a member of Phi Beta Kappa and Sigma Xi honorary societies.
"We expect to continue to see a focus on personalized, consumer-driven healthcare, powered by insights from data and analytics-powered tools"
[Arta Bakshandeh, Alignment Healthcare, via Parks Assoc. Aug 28, 2017]